Veeva Offers Complimentary eTMF Consultative Services
The Veeva TMF Maturity Model is available as a self-service online tool or as a more detailed, in-person evaluation with a subject matter expert.
Veeva Systems has established the Veeva TMF Maturity Model, a complimentary consultative service that assesses the state of a life sciences organization’s trial master file (TMF) strategy and provides a roadmap for improvement. It is available as a self-service online tool or as a more detailed, in-person evaluation with a subject matter expert.
Read the full release.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
Optimizing Phase III Oncology Trial Recruitment with Data-Driven Insights
February 3rd 2025A pharmaceutical company aimed to launch a Phase III clinical trial for a new oncology drug, focusing on efficient and effective patient recruitment across diverse regions. They evaluated patient populations by analyzing demographics, social determinants of health, and geography. Investigator profiling included practice details, affiliations, referral networks, and clinical trial experience. The final step involved selecting and extracting target lists for implementation.
